Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS
· Delayed Price · Currency is USD
1.880
-0.013 (-0.69%)
Dec 20, 2024, 4:00 PM EST
Medexus Pharmaceuticals Revenue
Medexus Pharmaceuticals had revenue of $26.30M in the quarter ending September 30, 2024, a decrease of -13.27%. This brings the company's revenue in the last twelve months to $104.76M, down -12.15% year-over-year. In the fiscal year ending March 31, 2024, Medexus Pharmaceuticals had annual revenue of $113.05M with 4.59% growth.
Revenue (ttm)
104.76M
Revenue Growth
-12.15%
P/S Ratio
n/a
Revenue / Employee
1.28M
Employees
82
Market Cap
48.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 113.05M | 4.96M | 4.59% |
Mar 31, 2023 | 108.10M | 31.40M | 40.93% |
Mar 31, 2022 | 76.70M | -2.96M | -3.71% |
Mar 31, 2021 | 79.66M | 24.15M | 43.52% |
Mar 31, 2020 | 55.51M | 21.64M | 63.91% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals News
- 4 weeks ago - Medexus and pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for Trecondyv (treosulfan for injection) in Canada - Newsfile Corp
- 6 weeks ago - Medexus Pharmaceuticals Inc. (MEDXF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Medexus Announces Strong Fiscal Q2 2025 Results - Newsfile Corp
- 7 weeks ago - Medexus Schedules Second Fiscal Quarter 2025 Conference Call - Newsfile Corp
- 3 months ago - Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors - Newsfile Corp
- 3 months ago - Medexus Provides Update on Treosulfan NDA Review Process and Extended PDUFA Goal Date - Newsfile Corp
- 4 months ago - Medexus Announces Strong Fiscal Q1 2025 Results - Newsfile Corp
- 5 months ago - Medexus Schedules First Fiscal Quarter 2025 Conference Call - Newsfile Corp